Target intelligence / Profile preview

Novel transcript, antisense to ACYP2 (ENSG00000296193)

Target
ENSG00000296193
Molecular classification
Long non-coding RNA (lncRNA)[3], Other (not enzyme, receptor, transporter, ion channel, transcription factor, or histone modifier)
01

Overview

This molecule is a long non-coding RNA transcript antisense to the ACYP2 gene. Natural antisense transcripts (NATs) are widespread in the genome and can regulate gene expression at the transcriptional or post-transcriptional level, often through interactions with their sense counterparts or by recruiting chromatin-modifying complexes[2]. While some NATs have well-established roles in gene regulation, imprinting, and disease, most remain uncharacterized, including this specific transcript. No experimental functions or roles in disease have been reported for ENSG00000296193, and there is currently no evidence that it is a therapeutically actionable target[3][2].

02

Mechanism of action

Not applicable; no drug-targeted mechanism is reported[3].

03

Biological functions

Regulation of gene expression (as a natural antisense transcript, could theoretically modulate the expression of ACYP2 or nearby genes[2].)Epigenetic regulation (by analogy to known NATs, might participate in chromatin modification, gene silencing, or alternative splicing[2].)

Beyond the preview

Go deeper on Novel transcript, antisense to ACYP2 (ENSG00000296193).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to ACYP2 (ENSG00000296193).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call